Results of CHOP chemotherapy for diffuse large B-cell lymphoma
Patients with diffuse large B-cell lymphoma treated in a University Hospital were studied from 1990 to 2001. Two treatment regimens were used: ProMACE-CytaBOM and then, from November 1996 on, the CHOP regimen. Complete remission (CR), disease-free survival (DFS), and overall survival (OS) rates were...
Main Authors: | A.E. Hallack Neto, J. Pereira, B. Beitler, D.A.F. Chamone, P.D. Llacer, F.L. Dulley, M.C.M.A. Macedo, A. Chaoubah |
---|---|
Format: | Article |
Language: | English |
Published: |
Associação Brasileira de Divulgação Científica
2006-10-01
|
Series: | Brazilian Journal of Medical and Biological Research |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2006001000007 |
Similar Items
-
Comparing R-Bendamustine vs. R-CHOP Plus Maintenance Therapy as First-Line Systemic Treatment in Follicular Lymphoma: A Multicenter Retrospective GELTAMO Study
by: Mariana Bastos-Oreiro, et al.
Published: (2024-03-01) -
A randomized controlled trial to assess safety and efficacy between terminal chop, stop and chop, and direct chop
by: Aprajita Sinha, et al.
Published: (2023-01-01) -
Comparison of first-line treatment with bendamustine plus rituximab versus R-CHOP for patients with follicular lymphoma grade 3A: Results of a retrospective study from the Fondazione Italiana Linfomi
by: Gloria Margiotta-Casaluci, et al.
Published: (2023-03-01) -
Comparison of “Nagahara Phaco-Chop” and “Stop-And-Chop Phacoemulsification Techniques”
by: Devrim Toslak, et al.
Published: (2018-07-01) -
Point and counterpoint: Polatuzumab vedotin in the front-line therapy for diffuse large B- cell lymphoma
by: Colin Thomas, et al.
Published: (2023-01-01)